JAMIE PARE: Open Payments
NPI 1558035709 · BOYNTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 27 payments from 14 companies in 2025. Trend: 2023 $1,054 · 2024 $1,008 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 7 | $112 |
| ABBVIE INC. | 3 | $83 |
| Lundbeck LLC | 2 | $69 |
| CSL Behring | 3 | $52 |
| PFIZER INC. | 2 | $51 |
| Merz Pharmaceuticals, LLC | 2 | $44 |
| Averitas Pharma Inc. | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $23 |
| Biogen, Inc. | 1 | $18 |
Products named: NUPLAZID, BOTOX, VYEPTI, Hizentra, NURTEC ODT, QUTENZA, INGREZZA, Xeomin.
Industry payments across FL — which companies pay providers there.
